Report

  • Home |
  • Reports |
  • Global Artificial Organ and Bionics Market by Types (Artificial Heart, Liver, Kidney Pancreas, Exosk....
src

Global Artificial Organ and Bionics Market by Types (Artificial Heart, Liver, Kidney Pancreas, Exoskeleton, Cochlear Implant) and by End-Users/Technology (Mechanical, Electronic) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2023 - 2032

 Report Code
 Category
 Published Date
 Pages
 Format
iSay-2179
Life Sciences
04 November 2023
210
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

Global Artificial Organ and Bionics Market

ISay Research has published a new report titled Artificial Organ and Bionics Market Share, Forecast Data, In-Depth Analysis and Forecast, 2022. According to the report, Global Artificial Organ and Bionics Market in 2022 stood at USD 34.30 billion and is expected to reach USD 83.46 billion by 2032 growing at a CAGR of 9.30% from 2023 to 2032.

Artificial organ is man-made machine that is used to replace the functions of missing or faulty organ and helps to reinstate the functions of original organ. Bionics denotes to the study of artificial body parts that provides natural biological capability. Organ transplantation has progressed as a common practice due to advancement of healthcare technology. Artificial organs and medical bionics is experiencing a wide growth because of high demand from the patients for organ transplantation surgery.

Artificial Organ and Bionics Market: Key Players

The research study includes profiles of leading companies operating in the global artificial organ and bionics market. Key players profiled in the report include: Zimmer Biomet, Medtronic, Abbott, ABIOMED INC., Berlin Heart Gmbh, Biomet Inc., Boston Scientific Corporation, Edward Lifesciences Corporation, Heartware International Inc. and Ekso Bionics.

Drivers for the Global Artificial Organ and Bionics Market:

Increasing number of transplants that are attached with the rising number of people that are waiting for donors, whereas in every 10 minutes a person is added to the transplant waiting list in the U.S., thereby considered as one of the major factor that is driving the growth of the global artificial organ and bionics market. Along with this, the number of people who has aged over 65 years are receiving and seeking organ transplants is another factor that is driving the growth of the global artificial organ and bionics market.

Opportunities for the Global Artificial Organ and Bionics Market:

Rise in lifestyle disorders because of unhealthy dietary habits, smoking, alcohol consumption, and lack of exercise are some major factors that will drive the growth of global artificial organ and bionics market in the forecast period. Along with this, rising advancements in the field of 3D bioprinting have proven to be crucial in organ transplanting as it is used for developing artificial organs, which is another factor that will enhance the growth of the global artificial organ and bionics market in the future.

Restrains for the Global Artificial Organ and Bionics Market:

High cost associated for the devices and surgery and uncertain reimbursement scenarios in different regions are some of the major factor that is hampering the growth of the global artificial organ and bionics market. Along with this, lack of surgical skills and expertise is also considered as the restraining factor of the global artificial organ and bionics market.

Region Wise, Global Artificial Organ and Bionics Market Analysis:

On the basis of region, the AIOps market is segmented into North America, South America, Europe, Asia Pacific, and the Middle East and Africa. North America held the largest share in the market because of increasing number of transplantation procedures, presence of well-developed healthcare facilities and local presence of many large biotechnology and medical devices companies. Asia Pacific is also having maximum share in the global artificial organ and bionics market which is followed by the Europe region.

Covid-19: Impact and Recovery Analysis for Global Artificial Organ and Bionics Market:

The world is greatly affected by the uncertain raise of the covid-19 Pandemic among the population. The Corona virus outbreak has disrupted & disturbed every sector of business as well as human activity. In most parts of the world there has been a complete restriction set by governments regarding various activities and in turn this is greatly affecting the financial stability of industries like: Artificial Organ and Bionics market globally. Most of the industries and businesses like: Artificial Organ and Bionics are shifting to manufacturing equipment that can support the covid-19 spread from increasing and spreading. This pandemic outbreak has several impact on the complete supply chain in the healthcare industry right from the obtaining of raw materials to manufacturing process and distribution channels. Along with the adverse impact of Covid-19, the healthcare industry is also getting benefits from increase awareness about healthcare, personal safety and the more government focus towards the safety of the public and society.

Global Artificial Organ and Bionics Market: Product analysis
  • Artificial Heart
  • Liver
  • Kidney Pancreas
  • Exoskeleton
  • Cochlear Implant
On the basis of type, Kidney Pancreas accounted for largest share of total revenue generated, because there is rise in the failure of kidney pancreas and manufacturers are fulfilling unmet demand to develop bio-lungs, artificial pancreas, and wearable artificial kidney.

Global Artificial Organ and Bionics Market: Technology analysis
  • Mechanical
  • Electronic
The demand of Global Artificial Organ and Bionics Market is highest from Mechanical bionics, because of the rising incidence of organ failure and the low cost of mechanical bionics.

Global Artificial Organ and Bionics Market: Region analysis
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • U.K.
  • France
  • Germany
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Argentina
  • Colombia
  • Rest of L.A.
  • Middle East and Africa
  • Turkey
  • GCC
  • UAE
  • South Africa
  • Rest of Middle East
Snapshot:
 
Attributes Details
Market Size in 2022 USD 34.30 Billion
Market Forecast in 2032 USD 83.46 Billion
Compound Annual Growth Rate (CAGR) 9.30 %
Unit Revenue (USD Million) and Volume (Kilo Tons)
Segmentation By Product Type, By Technology, By Region
By Product Type
  • Artificial Heart
  • Liver
  • Kidney Pancreas
  • Exoskeleton
  • Cochlear Implant
By Technology
  • Mechanical
  • Electronic
By Region
  • North America: U.S and Canada
  • Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
  • APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Chile
  • The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2022
Historical Year 2018 - 2032
Forecast Year 2023 - 2032
 
Pivotal Fundamentals of the Global Artificial Organ and Bionics Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each artificial organ and bionics market player.
  • Region-wise and country-wise breakdown of the artificial organ and bionics market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global artificial organ and bionics market.
  • Year-on-year growth of the global artificial organ and bionics market in terms of value and volume.
Conclusion:

At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish artificial organ and bionics market and nurture business as it explains current global market as well as future market.
 

Chapter 1 Artificial Organ and Bionics Overview
1.1 Product Overview and Scope of Artificial Organ and Bionics

Chapter 2 Impact of COVID 19
            2.1 Impact on Healthcare Industry
            2.2 Impact on Artificial Organ and Bionics
            2.3 Consumer Buying Behavior based on Artificial Organ and Bionics
            2.4 Recovery and forecast Analysis based on Artificial Organ and Bionics

Chapter 3 Executive Summary
            3.1 Drivers for Artificial Organ and Bionics:
            3.2 Restrain for Artificial Organ and Bionics:
            3.3 Opportunity for Artificial Organ and Bionics:
            3.4 Global Artificial Organ and Bionics, 2018 - 2032
            3.5 Global Artificial Organ and Bionics, by Region, 2018 - 2032
            3.6 Global Artificial Organ and Bionics, by Type, 2018 - 2032
            3.7 Global Artificial Organ and Bionics, by Technology, 2018 - 2032

Chapter 4 Artificial Organ and Bionics Segment by Types (Product Category)
            4.1 Global Artificial Organ and Bionics Revenue (USD Million) and Growth Rate (%) Comparison by Types (2018 - 2032)
            4.2 Global Artificial Organ and Bionics Revenue Market Share (%) by Types in 2022
            4.3 Artificial Heart
            4.4 Liver
            4.5 Kidney Pancreas
            4.6 Exoskeleton
            4.7 Cochlear Implant

Chapter 5 Global Artificial Organ and Bionics Segment by Technology
            5.1 Global Artificial Organ and Bionics Revenue (USD Million) Comparison by Technology (2018 - 2032)
            5.2 Mechanical
            5.3 Electronics

Chapter 6 Global Artificial Organ and Bionics by Regions (2018 - 2032)
            6.1 Global Artificial Organ and Bionics Size and Growth Rate (%) Comparison by Regions (2018 - 2032)
            6.2 North America Artificial Organ and Bionics Status and Prospect (2018 - 2032)
            6.3 Europe Artificial Organ and Bionics Status and Prospect (2018 - 2032)
            6.4 Asia Pacific Artificial Organ and Bionics Status and Prospect (2018 - 2032)
            6.5 South America Artificial Organ and Bionics Status and Prospect (2018 - 2032)
            6.6 Middle East & Africa Artificial Organ and Bionics Status and Prospect (2018 - 2032)
            6.7 Global Artificial Organ and Bionics Size (2018 - 2032)
            6.7.1 Global Artificial Organ and Bionics Revenue Status and Outlook (2018 - 2032)

Chapter 7 PESTEL Analysis
            7.1 Political Factors
            7.2 Economic Factors
            7.3 Social Factors
            7.4 Technological Factors
            7.5 Legal Factors
            7.6 Environment Factors

Chapter 8 Global Artificial Organ and Bionics Competition by Manufacturers
            8.1 Global Artificial Organ and Bionics Revenue and Share by Manufacturers (2018-2032)

Chapter 9 Company (Top Players) Profiles and Key Data
            9.1 Zimmer Biomet
                        9.1.1 Company Basic Information and Sales Area
                        9.1.2 Business Segment/ Overview
                        9.1.3 Investment in Research and Development
                        9.1.4 Artificial Organ and Bionics Product Types Specification
                        9.1.5 Key Developments
                        9.1.6 Business Strategy
            9.2 Medtronic
                        9.2.1 Company Basic Information and Sales Area
                        9.2.2 Business Segment/ Overview
                        9.2.3 Investment in Research and Development
                        9.2.4 Artificial Organ and Bionics Product Types Specification
                        9.2.5 Business Strategy
            9.3 Abbott
                        9.3.1 Company Basic Information and Sales Area
                        9.3.2 Business Segment/ Overview
                        9.3.3 Artificial Organ and Bionics Product Types Specification
                        9.3.4 Key Developments
                        9.3.5 Business Strategy
            9.4 ABIOMED INC.
                        9.4.1 Company Basic Information and Sales Area.
                        9.4.2 Business Segment/ Overview
                        9.4.3 Artificial Organ and Bionics Product Types Specification
                        9.4.4 Business Strategy
            9.5 Berlin Heart Gmbh
                        9.5.1 Company Basic Information and Sales Area.
                        9.5.2 Business Segment/ Overview
                        9.5.3 Artificial Organ and Bionics Product Types Specification
                        9.5.4 Business Strategy
            9.6 Biomet Inc.
                        9.6.1 Company Basic Information and Sales Area
                        9.6.2 Business Segment/ Overview
                        9.6.3 Artificial Organ and Bionics Product Types Specification
                        9.6.4 Business Strategy
            9.7 Boston Scientific Corporation
                        9.7.1 Company Basic Information and Sales Area
                        9.7.2 Business Segment/ Overview
                        9.7.3 Investment in Research and Development
                        9.7.4 Artificial Organ and Bionics Product Types Specification
                        9.7.5 Key Developments
                        9.7.6 Business Strategy
            9.8 Edward Lifesciences Corporation
                        9.8.1 Company Basic Information and Sales Area.
                        9.8.2 Business Segment/ Overview
                        9.8.3 Artificial Organ and Bionics Product Types Specification
                        9.8.4 Business Strategy
            9.9 Ekso Bionics
                        9.9.1 Company Basic Information and Sales Area
                        9.9.2 Business Segment/ Overview
                        9.9.3 Artificial Organ and Bionics Product Types Specification
                        9.9.4 Business Strategy
            9.10 Heartware International Inc.
                        9.10.1 Company Basic Information and Sales Area
                        9.10.2 Business Segment/ Overview
                        9.10.3 Artificial Organ and Bionics Product Types Specification
                        9.10.4 Business Strategy

Chapter 10 Global Artificial Organ and Bionics Revenue by Regions (2018 - 2032)
            10.1 Global Artificial Organ and Bionics Revenue and Market Share (%) by Regions (2018 - 2032)

Chapter 11 Global Artificial Organ and Bionics Revenue by Types
            11.1 Global Artificial Organ and Bionics Revenue and Market Share (%) by Types (2018 - 2032)

Chapter 12 Global Artificial Organ and Bionics Analysis by Technology
            12.1 Global Artificial Organ and Bionics Revenue (USD Million) and Market Share (%) by Technology (2018 - 2032)
            12.2 Global Artificial Organ and Bionics Revenue Growth Rate by Technology (2018 - 2032)

Chapter 13 North America Artificial Organ and Bionics Development Status and Outlook
            13.1 North America Artificial Organ and Bionics Size (2018 - 2032)
                        13.1.1 North America Artificial Organ and Bionics Size by Type (USD Million) (2018 - 2032)
            13.2 North America Artificial Organ and Bionics Size (2018 - 2032)
                        13.2.1 North America ARTIFICIAL ORGAN AND BIONICS Size by Technology (USD Million) (2018 - 2032)
            13.3 U.S
                        13.3.1 U.S. Artificial Organ and Bionics, by Type, 2018 - 2032
                        13.3.2 U.S. Artificial Organ and Bionics, by Technology, 2018 - 2032
            13.4 Canada
                        13.4.1 Canada Artificial Organ and Bionics, by Type, 2018 - 2032
                        13.4.2 Canada Artificial Organ and Bionics, by Technology, 2018 - 2032
            13.5 Mexico
                        13.5.1 Mexico Artificial Organ and Bionics, by Type, 2018 - 2032
                        13.5.2 Mexico Artificial Organ and Bionics, by Technology, 2018 - 2032

Chapter 14 Europe Artificial Organ and Bionics Development Status and Outlook
            14.1 Europe Artificial Organ and Bionics Size (2018 - 2032)
                        14.1.1 Europe Artificial Organ and Bionics Size by Type (USD Million) (2018 - 2032)
            14.2 Europe Artificial Organ and Bionics Size (2018 - 2032)
                        14.2.1 Europe Artificial Organ and Bionics Size by Technology (USD Million) (2018 - 2032)
            14.3 U.K.
                        14.3.1 U.K. Artificial Organ and Bionics, by Type, 2018 - 2032
                        14.3.2 U.K. Artificial Organ and Bionics, by Technology, 2018 - 2032
            14.4 Germany
                        14.4.1 Germany Artificial Organ and Bionics, by Type, 2018 - 2032
                        14.4.2 Germany Artificial Organ and Bionics, by Technology, 2018 - 2032
            14.5 France
                        14.5.1 France Artificial Organ and Bionics, by Type, 2018 - 2032
                        14.5.2 France Artificial Organ and Bionics, by Technology, 2018 - 2032
            14.6 Italy
                        14.6.1 Italy Artificial Organ and Bionics, by Type, 2018 - 2032
                        14.6.2 Italy Artificial Organ and Bionics, by Technology, 2018 - 2032
            14.7 Spain
                        14.7.1 Spain Artificial Organ and Bionics, by Type, 2018 - 2032
                        14.7.2 Spain Artificial Organ and Bionics, by Technology, 2018 - 2032
            14.8 Rest of Europe
                        14.8.1 Rest of Europe Artificial Organ and Bionics, by Type, 2018 - 2032
                        14.8.2 Rest of Europe Artificial Organ and Bionics, by Technology, 2018 - 2032

Chapter 15 Asia Pacific Artificial Organ and Bionics Development Status and Outlook
            15.1 Asia Pacific Artificial Organ and Bionics Size (2018 - 2032)
                        15.1.1 Asia Pacific Artificial Organ and Bionics Size by Type (USD Million) (2018 - 2032)
            15.2  Asia Pacific Artificial Organ and Bionics Size (2018 - 2032)
                        15.2.1 Asia Pacific ARTIFICIAL ORGAN AND BIONICS Size by Technology (USD Million) (2018 - 2032)
            15.3 China
                        15.3.1 China Artificial Organ and Bionics, by Type, 2018 - 2032
                        15.3.2 China Artificial Organ and Bionics, by Technology, 2018 - 2032
            15.4 Japan
                        15.4.1 Japan Artificial Organ and Bionics, by Type, 2018 - 2032
                        15.4.2 Japan Artificial Organ and Bionics, by Technology, 2018 - 2032
            15.5 India
                        15.5.1 India Artificial Organ and Bionics, by Type, 2018 - 2032
                        15.5.2 India Artificial Organ and Bionics, by Technology, 2018 - 2032
            15.6 Southeast Asia
                        15.6.1 Southeast Asia Artificial Organ and Bionics, by Type, 2018 - 2032
                        15.6.2 Southeast Asia Artificial Organ and Bionics, by Technology, 2018 - 2032

Chapter 16 South America Artificial Organ and Bionics Development Status and Outlook
            16.1 South America Artificial Organ and Bionics Size (2018 - 2032)
                        16.1.1 South America Artificial Organ and Bionics Size by Type (USD Million) (2018 - 2032)
            16.2 South America Artificial Organ and Bionics Size (2018 - 2032)
                        16.2.1 South America Artificial Organ and Bionics Size by Technology (USD Million) (2018 - 2032)
            16.3 Brazil
                        16.3.1 Brazil Artificial Organ and Bionics, by Type, 2018 - 2032
                        16.3.2 Brazil Artificial Organ and Bionics, by Technology, 2018 - 2032
            16.4 Argentina
                        16.4.1 Argentina Artificial Organ and Bionics, by Type, 2018 - 2032
                        16.4.2 Argentina Artificial Organ and Bionics, by Technology, 2018 - 2032
            16.5 Colombia
                        16.5.1 Colombia Artificial Organ and Bionics, by Type, 2018 - 2032
                        16.5.2 Colombia Artificial Organ and Bionics, by Technology, 2018 - 2032
            16.6 Rest of South America
                        16.6.1 Colombia Artificial Organ and Bionics, by Type, 2018 - 2032
                        16.6.2 Colombia Artificial Organ and Bionics, by Technology, 2018 - 2032

Chapter 17 Middle East & Africa Artificial Organ and Bionics Development Status and Outlook
            17.1 Middle East & Africa Artificial Organ and Bionics Size (2018 - 2032)
                        17.1.1 Middle East & Africa Artificial Organ and Bionics Size by Type (USD Million) (2018 - 2032)
            17.2 Middle East & Africa Artificial Organ and Bionics Size (2018 - 2032)
                        17.2.1 Middle East & Africa Artificial Organ and Bionics Size by Technology (2018 - 2032)
            17.3 UAE
                        17.3.1 UAE Artificial Organ and Bionics, by Type, 2018 - 2032
                        17.3.2 UAE Artificial Organ and Bionics, by Technology, 2018 - 2032
            17.4 South Africa
                        17.4.1 South Africa Artificial Organ and Bionics, by Type, 2018 - 2032
                        17.4.2 South Africa Artificial Organ and Bionics, by Technology, 2018 - 2032
            17.5 Egypt
                        17.5.1 Egypt Artificial Organ and Bionics, by Type, 2018 - 2032
                        17.5.2 Egypt Artificial Organ and Bionics, by Technology, 2018 - 2032
            17.6 Rest of MEA
                        17.6.1 Rest of MEA Artificial Organ and Bionics, by Type, 2018 - 2032
                        17.6.2 Rest of MEA Artificial Organ and Bionics, by Technology, 2018 - 2032

Chapter 18 Artificial Organ and Bionics Manufacturing Cost Analysis
            18.1 Proportion of Manufacturing Cost Structure
                        18.1.1 Raw Materials
                        18.1.2 Labor Cost
                        18.1.3 USA Labor Cost Analysis
                        18.1.4 EU Labor Costs Analysis
                        18.1.5 China Labor Costs Analysis
                        18.1.6 Manufacturing Expenses

Chapter 19 Marketing Strategy Analysis, Distributors/ Traders
            19.1 Marketing Channel
                        19.1.1 Direct Marketing
                        19.1.2 Indirect Marketing
                        19.1.3 Marketing Channel Development Trend
            19.2 Market Positioning
                        19.2.1 Pricing Strategy

Chapter 20 Global Artificial Organ and Bionics Forecast (2023-2032)
            20.1 Global Artificial Organ and Bionics Revenue Forecast (2023-2032)
                        20.1.1 Global Artificial Organ and Bionics Revenue (USD Million) and Growth Rate (%) Forecast (2023-2032)
            20.2 Global Artificial Organ and Bionics Revenue (USD Million) Forecast by Regions (2023-2032)
                        20.2.1 North America Artificial Organ and Bionics Revenue (USD Million) Forecast (2023-2032)
                        20.2.2 Europe Artificial Organ and Bionics Revenue (USD Million) Forecast (2023-2032)
                        20.2.3 Asia Pacific Artificial Organ and Bionics and Revenue (USD Million) Forecast (2023-2032)
                        20.2.4 South America Artificial Organ and Bionics and Revenue (USD Million) Forecast (2023-2032)
                        20.2.5 Middle East & Africa Artificial Organ and Bionics and Revenue (USD Million) Forecast (2023-2032)
            20.3 Global Artificial Organ and Bionics Revenue Forecast by Type (2023-2032)
            20.4 Global Artificial Organ and Bionics Revenue (USD Million) Forecast by Technology (2023-2032)

Chapter 21 North America Artificial Organ and Bionics Development Status and Outlook
            21.1 North America Artificial Organ and Bionics Size (2023-2032)
                        21.1.1 North America Artificial Organ and Bionics Size by Type (USD Million) (2023-2032)
            21.2 North America Artificial Organ and Bionics Size (2023-2032)
                        21.2.1 North America Artificial Organ and Bionics Size by Technology (USD Million) (2023-2032)
            21.3 U.S.
                        21.3.1 U.S. Artificial Organ and Bionics, by Type, 2023-2032
                        21.3.2 U.S. Artificial Organ and Bionics, by Technology, 2023-2032
            21.4 Canada
                        21.4.1 Canada Artificial Organ and Bionics, by Type, 2023-2032
                        21.4.2 Canada Artificial Organ and Bionics, by Technology, 2023-2032
            21.5 Mexico
                        21.5.1 Mexico Artificial Organ and Bionics, by Type, 2023-2032
                        21.5.2 Mexico Artificial Organ and Bionics, by Technology, 2023-2032

Chapter 22 Europe Artificial Organ and Bionics Development Status and Outlook
            22.1 Europe Artificial Organ and Bionics Size (2023-2032)
                        22.1.1 Europe Artificial Organ and Bionics Size by Type (USD Million) (2023-2032)
            22.2 Europe Artificial Organ and Bionics Size (2023-2032)
                        22.2.1 Europe Artificial Organ and Bionics Size by Technology (USD Million) (2023-2032)
            22.3 U.K.
                        22.3.1 U.K. Artificial Organ and Bionics, by Type, 2023-2032
                        22.3.2 U.K. Artificial Organ and Bionics, by Technology, 2023-2032
            22.4 Germany
                        22.4.1 Germany Artificial Organ and Bionics, by Type, 2023-2032
                        22.4.2 Germany Artificial Organ and Bionics, by Technology, 2023-2032
            22.5 France
                        22.5.1 France Artificial Organ and Bionics, by Type, 2023-2032
                        22.5.2 France Artificial Organ and Bionics, by Technology, 2023-2032
            22.6 Italy
                        22.6.1 France Artificial Organ and Bionics, by Type, 2023-2032
                        22.6.2 France Artificial Organ and Bionics, by Technology, 2023-2032
            22.7 Spain
                        22.7.1 France Artificial Organ and Bionics, by Type, 2023-2032
                        22.7.2 France Artificial Organ and Bionics, by Technology, 2023-2032
            22.8 Rest of Europe
                        22.8.1 France Artificial Organ and Bionics, by Type, 2023-2032
                        22.8.2 France Artificial Organ and Bionics, by Technology, 2023-2032

Chapter 23 Asia Pacific Artificial Organ and Bionics Development Status and Outlook
            23.1 Asia Pacific Artificial Organ and Bionics Size (2023-2032)
                        23.1.1 Asia Pacific Artificial Organ and Bionics Size by Type (USD Million) (2023-2032)
            23.2 Asia Pacific Artificial Organ and Bionics Size (2023-2032)
                        23.2.1 Asia Pacific Artificial Organ and Bionics Size by Technology (USD Million) (2023-2032)
            23.3 China
                        23.3.1 China Artificial Organ and Bionics, by Type, 2023-2032
                        23.3.2 China Artificial Organ and Bionics, by Technology, 2023-2032
            23.4 Japan
                        23.4.1 Japan Artificial Organ and Bionics, by Type, 2023-2032
                        23.4.2 Japan Artificial Organ and Bionics, by Technology, 2023-2032
            23.5 India
                        23.5.1 India Artificial Organ and Bionics, by Type, 2023-2032
                        23.5.2 India Artificial Organ and Bionics, by Technology, 2023-2032
            23.6 Southeast Asia
                        23.6.1 Southeast Asia Artificial Organ and Bionics, by Type, 2023-2032
                        23.6.2 Southeast Asia Artificial Organ and Bionics, by Technology, 2023-2032

Chapter 24 South America Artificial Organ and Bionics Development Status and Outlook
            24.1 South America Artificial Organ and Bionics Size (2023-2032)
                        24.1.1 South America Artificial Organ and Bionics Size by Type (USD Million) (2023-2032)
            24.2 South America Artificial Organ and Bionics Size (2023-2032)
                        24.2.1 South America Artificial Organ and Bionics Size by Technology (USD Million) (2023-2032)
            24.3 Brazil
                        24.3.1 Brazil Artificial Organ and Bionics, by Type, 2023-2032
                        24.3.2 Brazil Artificial Organ and Bionics, by Technology, 2023-2032
            24.4 Argentina
                        24.4.1 Argentina Artificial Organ and Bionics, by Type, 2023-2032
                        24.4.2 Argentina Artificial Organ and Bionics, by Technology, 2023-2032
            24.5 Colombia
                        24.5.1 Colombia Artificial Organ and Bionics, by Type, 2023-2032
                        24.5.2 Colombia Artificial Organ and Bionics, by Technology, 2023-2032
            24.6 Rest of South America
                        24.6.1 Colombia Artificial Organ and Bionics, by Type, 2023-2032
                        24.6.2 Colombia Artificial Organ and Bionics, by Technology, 2023-2032

Chapter 25 Middle East & Africa Artificial Organ and Bionics Development Status and Outlook
            25.1 Middle East & Africa Artificial Organ and Bionics Size (2023-2032)
                        25.1.1 Middle East & Africa Artificial Organ and Bionics Size by Type (USD Million) (2023-2032)
            25.2 Middle East & Africa Artificial Organ and Bionics Size (2023-2032)
                        25.2.1 Middle East & Africa Artificial Organ and Bionics Size by Technology (USD Million) (2023-2032)
            25.3 UAE
                        25.3.1 UAE Artificial Organ and Bionics, by Type, 2023-2032
                        25.3.2 UAE Artificial Organ and Bionics, by Technology, 2023-2032
            25.4 South Africa
                        25.4.1 South Africa Artificial Organ and Bionics, by Type, 2023-2032
                        25.4.2 South Africa Artificial Organ and Bionics, by Technology, 2023-2032
            25.5 Egypt
                        25.5.1 Egypt Artificial Organ and Bionics, by Type, 2023-2032
                        25.5.2 Egypt Artificial Organ and Bionics, by Technology, 2023-2032
            25.6 Rest of MEA
                        25.6.1 Rest of MEA Artificial Organ and Bionics, by Type, 2023-2032
                        25.6.2 Rest of MEA Artificial Organ and Bionics, by Technology, 2023-2032

Chapter 26 Research Findings and Conclusion

No Methodology

No Available

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase